Replies to post #99236 on Biotech Values

[Elroy Jetson]

There's nothing wrong with current trial design so long as you can remind yourself what they do and don't mean.

Not inferior at 48 weeks doesn't mean not inferior at 150 weeks.

Doctors and patients need to look past short-sighted marketing when other experience indicates it is likely to be misleading or wrong.

Thalidomide was safe for expectant mothers, but it ain't necessarily so.
.